Bae J.M., Kim E.H.: Epstein-Barr Virus infection and risk of breast cancer: an adaptive meta-analysis for case-control studies. Arch Clin Infect Dis 2016, 11, e34806.
Blake N., Lee S., Redchenko I., Thomas W., Steven N., Leese A., Steigerwald-Mullen P., Kurilla M.G., Frappier L., Rickinson A.: Human CD8 T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 1997, 7, 791–802.
Chiou S.H., Chow K.C., Yang C.H., Chiang S.F., Lin C.H.: Discovery of Epstein-Barr Virus (EBV)-encoded RNA signal and EBV nuclear antigen leader protein DNA sequence in pet dogs. J Gen Virol 2005, 86, 899–905.
Chiu H.C., Chow K.C., Fan Y.H., Chang S.C., Chiou S.H., Chiang S.F., Chiou C.H., Wu G.H., Yang H.C., Ho S.P., Chen Y.K., Lee W.C., Sun H.S.: Expression of EBV-encoded oncogenes and EBV-like virions in multiple canine tumors. Vet Microbiol 2013, 163, 79–89.
Cinque P., Brytting M., Vago L., Castagna A., Parravicini C., Zanchetta N., Monforte A.A., Wahren B., Lazzarin A., Linde A.: Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993, 342, 398–401.
Deshpande C.G., Badve S., Kidwai N., Longnecker R.: Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest 2002, 82, 1193–2002.
Glenn W.K., Heng B., Delprado W., Iacopetta B., Whitaker N.J., Lawson J.S.: Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012, 7, e48788.
Hu H., Luo M.L., Desmedt C., Nabavi S., Yadegarynia S., Hong A., Konstantinopoulos P.A., Gabrielson E., Hines-Boykin R., Pihan G., Yuan X., Sotirious C., Dittmer D.P., Fingeroth J.D., Wulf G.M.: Epstein–Barr virus infection of mammary epithelial cells promotes malignant transformation. E Bio Medicine 2016, 9, 148–160.
Huang S.H., Kozak P.J., Kim J., Habineza-Ndikuyeze G., Meade C., Gaurnier-Hausser A., Patel R., Robertson E., Mason N.J.: Evidence of an oncogenic gammaherpesvirus in domestic dogs. Virology 2012, 427, 107–117.
Ito D., Frantz A.M., Modiano J.F.: Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications. Vet Immunol Immunopathol 2014, 159, 192–201.
Karayannopoulou M., Kaldrymidou E., Constantinidis T.C., Dessiris A.: Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J Comp Pathol 2005, 133, 246–252.
Klopfleisch R., Lenze D., Hummel M., Gruber A.D.: Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer 2010, 10, 618.
Perrigoue J.G., Boon J.A., Friedl A., Newton M.A., Ahlquist P., Sugden B.: Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev 2005, 14, 809–814.
Rasotto R., Berlato D., Goldschmidt M.H., Zappulli V.: Prognostic significance of canine mammary tumor histologic subtypes: an observational cohort study of 229 cases. Vet Pathol 2017, 54, 571–578.
Sonmez K., Altan E., Yildirim F., Arun S.S., Turan N., Yilmaz H., Kuskucu M.A.: Investigation of human papillomaviruses (HPV), mouse mammary tumour virus (MMTV), Epstein–Barr virus (EBV), and human polyomavirus entities in canine mammary tumours. J Vet Res 2016, 60, 49–53.
Tomita Y., Ohsawa M., Mishiro Y., Kubo T., Maeshiro N., Kojya S., Noda Y., Aozasa K.: The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab Invest 1995, 73, 190–196.
Valente A.L., Schroeder B., Shriver C.D., Henning J.D., Ellsworth R.E.: Chronic inflammation in cancer: the role of human viruses. Adv Tumor Virol 2015, 5, 1–11.
Waugh E.M., Gallagher A., McAulay K.A., Henriques J., Alves M., Bell A.J., Morris J.S., Jarrett R.F.: Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas. J Gen Virol 2015, 96, 1863–1872.